Navigation Links
WebMD to Present at the 27th Annual J.P. Morgan Healthcare Conference
Date:1/12/2009

NEW YORK, Jan. 12 /PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD) and HLTH Corporation (Nasdaq: HLTH) today announced that executives of WebMD are scheduled to participate at the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2009 at 7:00 p.m. ET.

Investors, analysts and the general public are invited to listen to a live audio broadcast of the presentation over the Internet. The broadcast can be accessed at www.wbmd.com (in the Investor Relations section). A replay of the broadcast will be available at the same web address.

About WebMD

WebMD Health Corp. (Nasdaq: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers and health plans through our public and private online portals and health-focused publications. WebMD Health Corp. is a subsidiary of HLTH Corporation (Nasdaq: HLTH).

All statements contained in this press release, other than statements of historical fact, are forward-looking statements. These statements are based on WebMD's current plans and expectations and involve risks and uncertainties, including those described in our SEC filings.


'/>"/>
SOURCE WebMD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. WebMD Reports Preliminary Third Quarter Financial Results
2. WebMD to Present at Upcoming Investor Conferences
3. HLTH and WebMD Announce Fourth Quarter Earnings Release Date and Conference Call
4. WebMD to Present at the Morgan Stanley Technology Conference
5. HLTH and WebMD Announce First Quarter Earnings Release Date and Conference Call
6. WebMD Provides Preliminary First Quarter Results and Updates Financial Guidance for 2008
7. WebMD to Present at the Third Annual Needham & Company Internet & Digital Media Conference
8. WebMD Announces First Quarter Financial Results
9. WebMD to Present at the Goldman Sachs Ninth Annual Internet Conference
10. WebMD to Present at the William Blair 28th Annual Growth Stock Conference
11. GNC and WebMD Announce Agreement To Provide Consumers with Health and Nutritional Information While Promoting the Benefits of a Healthy Lifestyle

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...ELES, Nov. 9 Tracy Anderson, train...ate Hudson, will be hosting two events at her LA s...lly sharing her long awaited Nutritional Meal Plan...er TA Baby Food Cleanse and Lifestyle Menu. She w...tes her entire method of cardio and muscle structu...
(Date:11/9/2009)... men and women almost equally, study finds, , ...dely used clot-dissolving drug Plavix (clopidogrel...ysis of major clinical trials has found. , "Aft...eating both men and women with this very important...rdiovascular thrombosis at New York University Lan...
(Date:11/9/2009)...ue to fact that both eye conditions are age-relate...ealthDay News) -- Cataract surgery doesn,t appear ...generation (AMD), according to a new study that ch...ion loss worsens the other. , "Because both con... with cataract also have AMD," wrote Li Ming Dong,...
(Date:11/9/2009)...nted with new cells regained sexual function, stud... News) -- Researchers were able to restore sexual ...g new penile tissue in the lab and implanting it, ...on is a ways off, researchers say the technique co...nction in men. , "We were able to show the tiss...
(Date:11/9/2009)... Fast food chains are often blamed for...nt poll by Fitness.com.au however finds that 80% o...sponsibility. , (PRWEB) N..., and video games were behind Australia’s ob... than just innocent bystanders. A recent survey co...
Breaking Medicine News(10 mins):Health News:Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2
...athologists at The University of Texas Health Scie...modified protein that may help people with a hard-... as Hemophilia A. The discovery and the results of...III), people with Hemophilia A typically receive i...
...nterim results from a nationwide clinical trial le... researcher suggest that radiofrequency ablation i...ith Barretts esophagus, a condition that can lead ...placebo or sham treatment, said Dr. Nicholas Shahe...
...s money and time spent in intensive care units, re...y News) -- Endotracheal tubes coated with silver d...t bacteria, researchers report. , Patients on ven...ed pneumonia. , "Ventilator-associated pneumonia c...
... State University selected as winner, COLUMBUS, O...o 13 colleges and universities across the State of...will be added as registered organ and,tissue donor...ssue and eye,recovery agencies, partnered with the...
...NGTON HEIGHTS, Ill., May 19 Plastic,surgeons perf...ures in 2007,-- ranging from repairing dog bite wo...nstructing breasts following mastectomy., (Photo:...lives?, On average, members of The American Socie...
...rder triggered by gluten in common foods, such as ...DAY, May 19 (HealthDay News) -- New research could...c disease, according to studies presented at the D... small intestine triggered by a protein called glu...
Other Medicine News:Health News:Blood-clotting protein modified for people with hard-to-treat hemophilia 2Health News:Radiofrequency ablation is effective treatment for dysplasia in Barrett's esophagus 2Health News:Silver-Coated Endotracheal Tubes Cut Down on Infections 2Health News:Silver-Coated Endotracheal Tubes Cut Down on Infections 3Health News:Do It Now College Program Registers Nearly 125,000 New Organ and Tissue Donors 2Health News:Do It Now College Program Registers Nearly 125,000 New Organ and Tissue Donors 3Health News:Each Day, Plastic Surgeons Are Reconstructing Lives: Restoring Function, Improving Appearances, and Elevating Self-Esteem 2Health News:Advances Aid Treatment, Diagnosis of Celiac Disease 2Health News:Advances Aid Treatment, Diagnosis of Celiac Disease 3
(Date:11/9/2009)...IRMINGHAM, Ala., Nov. 9 ...hat it will host an investor conference call at 11..., to discuss its 2009 third quarter operating resu...ely an hour following the conclusion of the confer...cgi-bin/prnh/20080812/CLTU111LOGO ) ,, Pleas...
(Date:11/9/2009)...ATICK, Mass., Nov. 9 Bos...ounced its schedule of events at the 38th annual G...AAGL), which runs from November 15-19 in Orlando, ...e presented featuring the Company,s Urology/Gyneco...on systems and mid-urethral sling systems used to ...
(Date:11/9/2009)...EW YORK, Nov. 9 Keryx Bi...maceutical company focused on the acquisition, dev...ant pharmaceutical products for the treatment of l...al disease (the "Company"), today announced its re...09. ,, At September 30, 2009, the Company had c...
Breaking Medicine Technology:Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 4Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 5Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results 6HealthFitness Named Lead Integrator for MillerCoors Health Improvement Program 54748 1HealthFitness Named Lead Integrator for MillerCoors Health Improvement Program 54748 2HealthFitness Named Lead Integrator for MillerCoors Health Improvement Program 54748 3Exsulin Corporation Announces Publication of Phase 2 Trial Results for Novel Islet Regeneration Treatment in Type 1 26 Type 2 Diabetes 54746 1Exsulin Corporation Announces Publication of Phase 2 Trial Results for Novel Islet Regeneration Treatment in Type 1 26 Type 2 Diabetes 54746 2Exsulin Corporation Announces Publication of Phase 2 Trial Results for Novel Islet Regeneration Treatment in Type 1 26 Type 2 Diabetes 54746 3Exsulin Corporation Announces Publication of Phase 2 Trial Results for Novel Islet Regeneration Treatment in Type 1 26 Type 2 Diabetes 54746 47 Easy Tips for Healthy Aging 54745 17 Easy Tips for Healthy Aging 54745 2
... Meeting -, SOUTH SAN FRANCISCO, Calif. and CHICA...aceuticals, Inc. (Nasdaq: PARD ), a biopharmaceut...safety and efficacy results,from a previously unpu...iposomal doxorubicin in patients with advanced sol...strated signals of clinical activity and,acceptabl...
...sented at American Society of Clinical ....J., June 1 Medarex, Inc.,(Nasdaq: MEDX ) today ...survival (OS) results from a Phase 2 clinical stud...ion with dacarbazine (DTIC) where 11.4%, or 4 of,3...years of follow-up. This,included 1 patient that e...
Other Medicine Technology:Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 2Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 3Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 4
... The MNL 440601 Small Sledge Microtome is ideal fo...ally small dental or skin specimens. Specimen ris... setting from 2 30 microns in increments of 2 mic...ng Stages.,Other Associated Products, Vib...
Vibratome Starter Package, 230 Volt, 50/60 Hz
Vibratome Prof. Gold Package, 230 Volt, 50/60 Hz.
Vibratome Professional Package, 230 V. 50/60Hz
Medicine Products: